Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3INDIV 1

Study Type

Observational 2Interventional 1

Sponsor

Conditions

Myasthenia Gravis 3Carcinoma, Hepatocellular 2Skin Neoplasms 1Nervous System Diseases 1Autoimmune Diseases 1

Interventions

Rituximab 7Pyridostigmine Bromide 5Prednisone 5efgartigimod alfa 4Hizentra 4telitacicept 3Immunoglobulins, Intravenous 3Cyclophosphamide 3Azathioprine 3thymoglobulin 2fludarabine 2Thymectomy 2Steroids 2Mycophenolic Acid 2Data Collection 2Blood Specimen Collection 2zilucoplan 1tofacitinib 1tocilizumab 1talquetamab 1sargramostim 1rozanolixizumab 1prednylidene 1gamma-Globulins 1deltacortene 1carmustine, poliferprosan 20 drug combination 1bu-zhong-yi-qi-tang 1apraclonidine 1Walk Test 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Myasthenia Gravis × Azathioprine × Clear all
NCT04182984 2026-01-30

TREAT-OMG

Tang-Du Hospital

Recruiting
200 enrolled

Myasthenia Gravis

NCT01727193 2022-04-14

The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy

First Affiliated Hospital, Sun Yat-Sen University

Phase 3 Completed
290 enrolled

Myasthenia Gravis

NCT03490539 2021-02-03

PROMISE-MG

Duke University

Completed
167 enrolled

Autoimmune Diseases, Myasthenia Gravis, Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡